Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Editor’s Picks: Gold Tariff Threat Ends, Price Reacts... August 16, 2025 A$3.5M Institutional Placement and New Chairman Appointed May 26, 2025 Newmont Withdraws from Mount Coolon Joint Venture, GBM... September 17, 2025 Results of Channel Sampling Program at Halleck Creek May 8, 2025 Top 5 Canadian Mining Stocks This Week: Avanti... July 12, 2025 Acquisition of Silver Extraction Technology August 12, 2025 Graphite Market Update: H1 2025 in Review August 19, 2025 CEO & COO Appointed to Fast Track US... September 25, 2025 Bert Dohmen: Gold, Silver Key as Stock Market... July 4, 2025 Top 5 Canadian Mining Stocks This Week: Royalties... June 21, 2025